Latest AMYT reports update at 2023-12-23: 2021 ∙ 2020 ∙ 2019

Amryt Pharma plc AMYT

$ 14.7 0.0%

Amryt Pharma plc Balance Sheet 2011-2024 | AMYT

Annual Balance Sheet Amryt Pharma plc

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	70.6 M	112 M	7.78 M	-11.2 M	-8.7 M	-16.8 M	-17.4 M	-31.5 M	-239 K	-1.61 K
Long Term Debt	-	188 M	178 M	19 M	12.7 M	-	-	-	-	-	-
Long Term Debt Current	1.54 M	963 K	571 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	369 M	-	72.5 M	58.1 M	30.2 M	-	79 K	169 K	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	459 M	470 M	395 M	84.5 M	69.8 M	33.9 M	504 K	13.2 M	842 K	439 K	43.4 K
Deferred Revenue	-	-	23 M	-	-	-	-	-	-	-	-
Retained Earnings	-	-236 M	84 M	-69.6 M	-42.1 M	-9.46 M	-44.8 M	-5.05 M	-2.49 M	-3.11 M	-3.72 M
Total Assets	816 M	537 M	527 M	80.8 M	96.1 M	68.7 M	17 M	69.2 M	43.7 M	698 K	1.13 M
Cash and Cash Equivalents	113 M	119 M	67.2 M	11.2 M	-	-	-	-	-	-	-
Book Value	357 M	66.1 M	132 M	-3.7 M	26.3 M	34.7 M	16.5 M	55.9 M	42.8 M	259 K	1.09 M
Total Shareholders Equity	-	66.1 M	132 M	-3.7 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Amryt Pharma plc

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	4.05 M	-	-	-	4.57 M	-	-	-	1.05 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	302 M	-	-	-	369 M	-	-	-	293 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	459 M	-	-	-	470 M	-	-	-	395 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-233 M	-	-	-	-236 M	-	-	-	-131 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	816 M	-	-	-	537 M	-	-	-	527 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	113 M	-	-	-	119 M	-	-	-	67.2 M	-	-	-	11.2 M	-	-	-	24.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	357 M	-	-	-	66.1 M	-	-	-	132 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	357 M	-	-	-	66.1 M	-	-	-	132 M	-	-	-	-3.7 M	-	-	-	26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency